Stem cell therapy for ischemic heart diseases.

about

Hypoxia preconditioning promotes cardiac stem cell survival and cardiogenic differentiation in vitro involving activation of the HIF-1α/apelin/APJ axis.Stem Cell-Derived Exosome in Cardiovascular Diseases: Macro Roles of Micro Particles.The use of stem cells in ischemic heart disease treatment

P2860

Q42368086-E3757B8B-335F-4299-9624-A84621D05A35 Q55071721-78D69B66-F6C9-4F0F-93E4-398D3E3EE554 Q57494730-C941B860-1D42-426B-A6E3-7667AC7D8ADD

P2860

Stem cell therapy for ischemic heart diseases.

Item

http://www.wikidata.org/entity/Q38761212

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Stem cell therapy for ischemic heart diseases.

@en

type

Item

label

Stem cell therapy for ischemic heart diseases.

@en

prefLabel

Stem cell therapy for ischemic heart diseases.

@en

P1476

Stem cell therapy for ischemic heart diseases.

@en

P2093

Jian'an Wang

http://www.w3.org/2001/XMLSchema#string

Jinyun Zhu

http://www.w3.org/2001/XMLSchema#string

Kai Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Mesenchymal stem cells avoid allogeneic rejection

Evidence for cardiomyocyte renewal in humans

Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells

Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs

Concise review: Circulating endothelial progenitor cells for vascular medicine

Immunosuppression of allogenic mesenchymal stem cells transplantation after spinal cord injury improves graft survival and beneficial outcomes.

Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22

Preconditioning via angiotensin type 2 receptor activation improves therapeutic efficacy of bone marrow mononuclear cells for cardiac repair

Induced pluripotent stem cell lines derived from human somatic cells

Multilineage potential of adult human mesenchymal stem cells

P304

135-154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BMB/LDW059

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Hong Yu

P577

2017-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28164211

http://www.w3.org/2001/XMLSchema#string

Stem cell therapy for ischemic heart diseases.

about

P2860

P2860

Stem cell therapy for ischemic heart diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698